CN103360609B - 一种双亲性的蛋白质-高分子键合体及其制备方法 - Google Patents
一种双亲性的蛋白质-高分子键合体及其制备方法 Download PDFInfo
- Publication number
- CN103360609B CN103360609B CN201310299095.7A CN201310299095A CN103360609B CN 103360609 B CN103360609 B CN 103360609B CN 201310299095 A CN201310299095 A CN 201310299095A CN 103360609 B CN103360609 B CN 103360609B
- Authority
- CN
- China
- Prior art keywords
- pcl
- bsa
- maleimide
- preparation
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 claims abstract description 31
- 238000000502 dialysis Methods 0.000 claims abstract description 30
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims abstract description 30
- 238000006243 chemical reaction Methods 0.000 claims abstract description 28
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims abstract description 20
- 238000000034 method Methods 0.000 claims abstract description 12
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 7
- 230000008569 process Effects 0.000 claims abstract description 5
- 238000006957 Michael reaction Methods 0.000 claims abstract description 3
- 229920001610 polycaprolactone Polymers 0.000 claims description 107
- 239000004632 polycaprolactone Substances 0.000 claims description 95
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 48
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 40
- 229940098773 bovine serum albumin Drugs 0.000 claims description 40
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 29
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 24
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 238000004108 freeze drying Methods 0.000 claims description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 12
- 230000035484 reaction time Effects 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 8
- 229960001701 chloroform Drugs 0.000 claims description 8
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 16
- 239000003937 drug carrier Substances 0.000 abstract description 13
- 239000000463 material Substances 0.000 abstract description 8
- 238000001338 self-assembly Methods 0.000 abstract description 7
- -1 polyoxyethylene Polymers 0.000 description 7
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 238000013019 agitation Methods 0.000 description 6
- 238000004090 dissolution Methods 0.000 description 6
- 238000004821 distillation Methods 0.000 description 6
- 244000144992 flock Species 0.000 description 6
- 238000001291 vacuum drying Methods 0.000 description 6
- 238000010792 warming Methods 0.000 description 6
- 102000009027 Albumins Human genes 0.000 description 5
- 108010088751 Albumins Proteins 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 3
- 108091006905 Human Serum Albumin Proteins 0.000 description 2
- 102000008100 Human Serum Albumin Human genes 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 229920001477 hydrophilic polymer Polymers 0.000 description 2
- 229920001600 hydrophobic polymer Polymers 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000000693 micelle Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920000747 poly(lactic acid) Polymers 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- JGENYNHRIOHZOP-UHFFFAOYSA-N ethyl 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCOP([O-])(=O)OCC[N+](C)(C)C JGENYNHRIOHZOP-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
- 229920002946 poly[2-(methacryloxy)ethyl phosphorylcholine] polymer Polymers 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310299095.7A CN103360609B (zh) | 2013-07-16 | 2013-07-16 | 一种双亲性的蛋白质-高分子键合体及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310299095.7A CN103360609B (zh) | 2013-07-16 | 2013-07-16 | 一种双亲性的蛋白质-高分子键合体及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103360609A CN103360609A (zh) | 2013-10-23 |
CN103360609B true CN103360609B (zh) | 2015-08-19 |
Family
ID=49362926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310299095.7A Active CN103360609B (zh) | 2013-07-16 | 2013-07-16 | 一种双亲性的蛋白质-高分子键合体及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103360609B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112442180B (zh) * | 2019-09-04 | 2022-04-01 | 北京化工大学 | 一种用于促进干细胞界面粘附生长的双亲性聚合物及其制备方法和用途 |
CN115397846A (zh) * | 2020-03-06 | 2022-11-25 | 昆山新蕴达生物科技有限公司 | 疏水性修饰的白蛋白及其制备方法和用途 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102697735A (zh) * | 2012-06-18 | 2012-10-03 | 南京大学医学院附属鼓楼医院 | 负载碱性抗肿瘤药物的高分子纳米粒子 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005298486A (ja) * | 2004-03-15 | 2005-10-27 | Nipro Corp | リポソームを含む癌治療用医薬組成物 |
US20120201873A1 (en) * | 2009-08-05 | 2012-08-09 | Pieris Ag | Controlled release formulations of lipocalin muteins |
-
2013
- 2013-07-16 CN CN201310299095.7A patent/CN103360609B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102697735A (zh) * | 2012-06-18 | 2012-10-03 | 南京大学医学院附属鼓楼医院 | 负载碱性抗肿瘤药物的高分子纳米粒子 |
Non-Patent Citations (1)
Title |
---|
牛血清白蛋白脂质体包封率的测定方法研究;侯冬枝等;《药学学报》;20071231;第42卷(第5期);545-549 * |
Also Published As
Publication number | Publication date |
---|---|
CN103360609A (zh) | 2013-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kowalski et al. | Smart biomaterials: recent advances and future directions | |
Yang et al. | Composition-engineered metal–organic framework-based microneedles for glucose-mediated transdermal insulin delivery | |
CN108542885B (zh) | 抗肿瘤药物及其制备方法 | |
CN105997880B (zh) | 一种基于交联生物可降解聚合物囊泡的抗肿瘤纳米药物及其制备方法 | |
Kang et al. | Tailoring the stealth properties of biocompatible polysaccharide nanocontainers | |
Schwall et al. | Micro-and nanoscale hydrogel systems for drug delivery and tissue engineering | |
CA3009252C (en) | Biodegradable amphiphilic polymer, polymeric vesicles prepared therefrom, and application of biodegradable amphiphilic polymer in preparation of medicines for targeted therapy of lung cancer | |
Hori et al. | Robust polyion complex vesicles (PICsomes) under physiological conditions reinforced by multiple hydrogen bond formation derived by guanidinium groups | |
CN101787119A (zh) | 一种具有肿瘤组织pH响应性的聚合物及其胶束 | |
CN102604065B (zh) | 交联的生物可降解载体聚合物、胶束、囊泡及其制备方法和应用 | |
CN105968372B (zh) | 一种自发荧光纳米凝胶及其制备方法与应用 | |
CN102634033A (zh) | 葡聚糖基两亲性嵌段共聚物制备方法 | |
Han et al. | Recent advances of poly (ester amide) s-based biomaterials | |
CN109200012A (zh) | 一种含有无机盐的分层溶解微针 | |
CN104487093B (zh) | 经由不含铜的环加成的基于peg的水凝胶的应变促进的交联 | |
CN103360609B (zh) | 一种双亲性的蛋白质-高分子键合体及其制备方法 | |
CN101766819A (zh) | 肝素复合物及其制备方法与应用 | |
Gong et al. | pH-responsive cellulose-based microspheres designed as an effective oral delivery system for insulin | |
KR101850424B1 (ko) | 조직접착용 포스파젠계 고분자, 이의 제조방법 및 용도 | |
Simon et al. | Exploring the role of polymers to overcome ongoing challenges in the field of extracellular vesicles | |
Chen et al. | Recent Trends in the Development of Polyphosphazenes for Bio-applications | |
CN105920614A (zh) | 一种超分子水凝胶药物与基因双重载体材料及其制备方法 | |
CN100434120C (zh) | 两亲性荧光靶向纳米胶束及其制备方法 | |
CN106188550B (zh) | 树枝状嵌段共聚物PAM-PGlu-b-TPGS及其制备方法与应用 | |
JP2010064956A (ja) | 粒子およびその製造方法、ならびにゲル |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210908 Address after: Room 109, no.1866, Bohai 12th Road, Port Economic Zone, Binhai New Area, Tianjin 300452 Patentee after: Tianjin Bohua Xinchuang Technology Co.,Ltd. Address before: 300072 Tianjin City, Nankai District Wei Jin Road No. 92, Tianjin University Patentee before: Tianjin University |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20131023 Assignee: TIANJIN SHENGJI GROUP Co.,Ltd. Assignor: Tianjin Bohua Xinchuang Technology Co.,Ltd. Contract record no.: X2024980002161 Denomination of invention: A amphiphilic protein polymer bond complex and its preparation method Granted publication date: 20150819 License type: Common License Record date: 20240222 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
OL01 | Intention to license declared | ||
OL01 | Intention to license declared | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20131023 Assignee: Tianjin Haiguang Technology Development Co.,Ltd. Assignor: Tianjin Bohua Xinchuang Technology Co.,Ltd. Contract record no.: X2024980003898 Denomination of invention: A amphiphilic protein polymer bond complex and its preparation method Granted publication date: 20150819 License type: Common License Record date: 20240403 |
|
EE01 | Entry into force of recordation of patent licensing contract |